Literature DB >> 32037470

Profound effect of post-rituximab mycophenolate mofetil administration for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome.

Shuichiro Fujinaga1, Yuji Tomii2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32037470     DOI： 10.1007/s10157-020-01858-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


× No keyword cloud information.
  4 in total

1.  Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.

Authors:  Cyrielle Parmentier; Jean-Daniel Delbet; Stéphane Decramer; Olivia Boyer; Julien Hogan; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2019-11-08       Impact factor: 3.714

2.  Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.

Authors:  Shuichiro Fujinaga; Daishi Hirano; Akira Mizutani; Koji Sakuraya; Akifumi Yamada; Shunsuke Sakurai; Toshiaki Shimizu
Journal:  Clin Exp Nephrol       Date:  2016-08-24       Impact factor: 2.801

3.  Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.

Authors:  Shuichiro Fujinaga; Kanako Ozawa; Koji Sakuraya; Akifumi Yamada; Toshiaki Shimizu
Journal:  Clin Nephrol       Date:  2016-06       Impact factor: 0.975

4.  Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values.

Authors:  Pierluigi Marzuillo; Stefano Guarino; Tiziana Esposito; Anna Di Sessa; Sara Immacolata Orsini; Daniela Capalbo; Emanuele Miraglia Del Giudice; Angela La Manna
Journal:  World J Clin Cases       Date:  2019-05-06       Impact factor: 1.337
  4 in total
  2 in total

1.  The association between hypogammaglobulinemia severity and infection risk in rituximab-treated patients with childhood-onset idiopathic nephrotic syndrome.

Authors:  Yuta Inoki; Kentaro Nishi; Mai Sato; Masao Ogura; Koichi Kamei
Journal:  Pediatr Nephrol       Date:  2022-06-24       Impact factor: 3.714

2.  Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.

Authors:  Yuta Inoki; Koichi Kamei; Kentaro Nishi; Mai Sato; Masao Ogura; Akira Ishiguro
Journal:  Pediatr Nephrol       Date:  2021-10-04       Impact factor: 3.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.